Dermatology · Phase 3 · Enrollment

Vitiligo Clinical Trial Enrollment: WCR Phase 3 Case

A procedure-intensive Phase 3 vitiligo study connects recruitment delivery with the practical work of supporting lengthy visits.

Study experience and results: Wellness Clinical Research. Perspective by Wellness Global Research.

WCR-reported study results

15Participants randomized
8Original randomization forecast
87.5%Above that forecast

Participation involved more than appointments

Clinical photography and detailed skin assessments made this study a meaningful time commitment. WCR describes preparing candidates for those demands and helping participants manage scheduling and transportation. Meals were provided during particularly long appointments when needed.

Keep the outcomes distinct

The site reports 15 randomized participants against an original forecast of eight, together with a study audit that had no findings. It also reports two participants lost to follow-up and one early withdrawal. The source does not establish a final completed-participant total, so enrollment delivery and long-term follow-through remain separate parts of this case.

What to examine during feasibility

For a dermatology protocol, patient access needs to be considered alongside photography, assessment time, room availability, and visit support. WGR helps bring those operational details into the site-selection discussion. A useful forecast explains the work needed to support participation, as well as the candidate pool.

Apply the questions to your protocol

Connect the experience
to the study ahead.

Discuss investigator fit, patient access, study resources, and the support model with WGR’s central team.

Discuss your studyReview sponsor capabilities

Original source

Vitiligo Clinical Trial Enrollment: WCR Phase 3 Case at Wellness Clinical Research

WCR is WGR’s sister company. These are WCR’s reported study outcomes, presented here with original WGR commentary.

Related experience

Keep exploring.